IN2014DN09367A - - Google Patents

Download PDF

Info

Publication number
IN2014DN09367A
IN2014DN09367A IN9367DEN2014A IN2014DN09367A IN 2014DN09367 A IN2014DN09367 A IN 2014DN09367A IN 9367DEN2014 A IN9367DEN2014 A IN 9367DEN2014A IN 2014DN09367 A IN2014DN09367 A IN 2014DN09367A
Authority
IN
India
Prior art keywords
cpavkrdvdlflt
peptides
seq
combinations
sequence
Prior art date
Application number
Other languages
English (en)
Inventor
Paul LAD3LER
Imre Farkas
Original Assignee
Circassia Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Circassia Ltd filed Critical Circassia Ltd
Publication of IN2014DN09367A publication Critical patent/IN2014DN09367A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/35Allergens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/57Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/577Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 tolerising response

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
IN9367DEN2014 2012-05-11 2013-05-09 IN2014DN09367A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB201208293A GB201208293D0 (en) 2012-05-11 2012-05-11 Hydrochlorice salt of peptide
PCT/GB2013/051201 WO2013167897A1 (en) 2012-05-11 2013-05-09 Hydrochloride salt of peptide and its use in combination with other peptides for immunotherapy

Publications (1)

Publication Number Publication Date
IN2014DN09367A true IN2014DN09367A (de) 2015-07-17

Family

ID=46396890

Family Applications (1)

Application Number Title Priority Date Filing Date
IN9367DEN2014 IN2014DN09367A (de) 2012-05-11 2013-05-09

Country Status (17)

Country Link
US (1) US9657061B2 (de)
EP (1) EP2847209B8 (de)
JP (1) JP5982562B2 (de)
KR (1) KR20150014955A (de)
CN (1) CN104428311B (de)
AU (1) AU2013257784A1 (de)
BR (1) BR112014028130A2 (de)
CA (1) CA2873120A1 (de)
EA (1) EA201492068A1 (de)
GB (2) GB201208293D0 (de)
HK (1) HK1201850A1 (de)
IL (1) IL235388A (de)
IN (1) IN2014DN09367A (de)
MX (1) MX2014013394A (de)
SG (1) SG11201407446TA (de)
WO (1) WO2013167897A1 (de)
ZA (1) ZA201408290B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201406569D0 (en) 2014-04-11 2014-05-28 Stabilitech Ltd Vaccine compositions
MA48487B1 (fr) 2014-12-23 2021-11-30 Immatics Biotechnologies Gmbh Nouveaux peptides et combinaison de peptides à utiliser dans l'immunothérapie contre le carcinome hépatocellulaire (hcc) et d'autres cancers
GB201501017D0 (en) * 2014-12-23 2015-03-04 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
GB201505305D0 (en) 2015-03-27 2015-05-13 Immatics Biotechnologies Gmbh Novel Peptides and combination of peptides for use in immunotherapy against various tumors
GB2562241B (en) 2017-05-08 2022-04-06 Stabilitech Biopharma Ltd Vaccine compositions
TWI792442B (zh) * 2021-07-23 2023-02-11 建誼生技股份有限公司 依特卡肽鹽酸鹽之製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1453539B1 (de) * 2001-12-05 2008-11-19 Circassia Limited Immunotherapeutische methoden und systeme
MX2008009125A (es) 2006-01-18 2008-10-23 Qps Llc Composiciones farmaceuticas con estabilidad mejorada.
GB0710529D0 (en) * 2007-06-01 2007-07-11 Circassia Ltd Vaccine
CN101820907B (zh) * 2007-08-15 2013-05-01 切尔卡西亚有限公司 针对过敏原去敏化的肽
GB2455108A (en) * 2007-11-28 2009-06-03 Circassia Ltd T-Cell dependent method for detecting non-allergic or intrinsic disorders
GB0821806D0 (en) 2008-11-28 2009-01-07 Circassia Ltd Compositions with reduced dimer formation
US20130164296A1 (en) * 2010-03-31 2013-06-27 Jeffrey Drew Excipients for Stabilising Viral Particles, Polypeptides or Biological Material

Also Published As

Publication number Publication date
EA201492068A1 (ru) 2015-03-31
MX2014013394A (es) 2015-02-04
ZA201408290B (en) 2016-01-27
AU2013257784A1 (en) 2014-11-20
EP2847209B8 (de) 2020-10-07
SG11201407446TA (en) 2015-03-30
HK1201850A1 (en) 2015-09-11
US9657061B2 (en) 2017-05-23
CN104428311A (zh) 2015-03-18
BR112014028130A2 (pt) 2017-08-15
EP2847209B1 (de) 2020-08-05
GB201208293D0 (en) 2012-06-20
CA2873120A1 (en) 2013-11-14
WO2013167897A1 (en) 2013-11-14
KR20150014955A (ko) 2015-02-09
GB201421491D0 (en) 2015-01-14
IL235388A (en) 2016-06-30
US20150110820A1 (en) 2015-04-23
EP2847209A1 (de) 2015-03-18
GB2517354A (en) 2015-02-18
JP5982562B2 (ja) 2016-08-31
CN104428311B (zh) 2019-11-01
JP2015517484A (ja) 2015-06-22

Similar Documents

Publication Publication Date Title
WO2013000922A9 (en) Ccr2 antagonist peptides
MX2020010399A (es) 3-epimerasa.
UA118167C2 (uk) Пептид та його застосування
NZ629394A (en) Synthetic brassica-derived chloroplast transit peptides
GB201206559D0 (en) Polypeptide
MX2018007955A (es) Proceso de preparacion de agonistas c de guanilato cliclasa.
IN2014DN09367A (de)
IL233280B (en) Cell-penetrating peptides
MX2013001580A (es) Composiciones que comprenden un polipeptido que tiene actividad de incremento celulolitico y un licor, y usos de las mismas.
JO3154B1 (ar) عوامل مضادة لـ trpv4
EA033145B1 (ru) Применение полученных из pedf пептидов в стимуляции регенерации мышцы, регенерации сухожилия или артериогенеза
EP2812018A4 (de) Neuartige sp-b- und sp-c peptide, tenside für eine synthetische lunge und verwendung davon
NZ706884A (en) Fc gamma receptor iib variants
SG191332A1 (en) Recombinant mycobacterium as a vaccine
EP2822654A4 (de) Oral aktives, zellenpenetrierendes homing peptid und verwendungsverfahren dafür
WO2011034659A3 (en) Advantageous mu-opiate receptor peptide compounds
MX2014006869A (es) Cassette de expresion.
IN2014MN01376A (de)
MX362058B (es) Péptido pntx(19) sintético, composición farmacéutica y uso.
EP2593546A4 (de) Affinitätsreinigung von rna unter nativen bedingungen auf basis der lambda-box-b/n-peptid-interaktion
CA2909744C (en) Protransduzin b, an enhancer of gene transfer
MX2010011055A (es) Derivados peptidicos de opiorfina como potentes inhibidores de ectopeptidasas degradadoras de encefalinas.
WO2012102625A3 (en) Therapeutic composition
GB2526222A (en) Viral peptides
EA201590431A1 (ru) Пшеница с новыми аллелями rht-b1